Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Cash generated from core business operations
Latest
$-63.66M
↓ 75% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-36.48M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-63.66M | +3.1% |
| 2024 | $-65.67M | -54.0% |
| 2023 | $-42.64M | -41.6% |
| 2022 | $-30.12M | -115.4% |
| 2021 | $-13.98M | -398.8% |
| 2020 | $-2.80M | - |